1. Home
  2. MRKR vs UCAR Comparison

MRKR vs UCAR Comparison

Compare MRKR & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • UCAR
  • Stock Information
  • Founded
  • MRKR N/A
  • UCAR 2013
  • Country
  • MRKR United States
  • UCAR China
  • Employees
  • MRKR N/A
  • UCAR N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • UCAR Retail-Auto Dealers and Gas Stations
  • Sector
  • MRKR Health Care
  • UCAR Consumer Discretionary
  • Exchange
  • MRKR Nasdaq
  • UCAR Nasdaq
  • Market Cap
  • MRKR 11.6M
  • UCAR 10.0M
  • IPO Year
  • MRKR N/A
  • UCAR 2023
  • Fundamental
  • Price
  • MRKR $0.96
  • UCAR $2.05
  • Analyst Decision
  • MRKR Strong Buy
  • UCAR Strong Buy
  • Analyst Count
  • MRKR 3
  • UCAR 1
  • Target Price
  • MRKR $13.17
  • UCAR $5.00
  • AVG Volume (30 Days)
  • MRKR 2.7M
  • UCAR 23.8K
  • Earning Date
  • MRKR 11-13-2025
  • UCAR 10-07-2025
  • Dividend Yield
  • MRKR N/A
  • UCAR N/A
  • EPS Growth
  • MRKR N/A
  • UCAR N/A
  • EPS
  • MRKR N/A
  • UCAR N/A
  • Revenue
  • MRKR $5,388,071.00
  • UCAR $6,067,871.00
  • Revenue This Year
  • MRKR N/A
  • UCAR N/A
  • Revenue Next Year
  • MRKR $15.82
  • UCAR N/A
  • P/E Ratio
  • MRKR N/A
  • UCAR N/A
  • Revenue Growth
  • MRKR 44.55
  • UCAR 124.09
  • 52 Week Low
  • MRKR $0.81
  • UCAR $1.74
  • 52 Week High
  • MRKR $5.95
  • UCAR $9.43
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 41.99
  • UCAR 50.45
  • Support Level
  • MRKR $0.91
  • UCAR N/A
  • Resistance Level
  • MRKR $1.02
  • UCAR $2.14
  • Average True Range (ATR)
  • MRKR 0.06
  • UCAR 0.09
  • MACD
  • MRKR 0.02
  • UCAR -0.03
  • Stochastic Oscillator
  • MRKR 72.00
  • UCAR 95.97

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: